APEIRON Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-19

Written by Petra Hegmann on 2nd April 2020. Posted in Client News.

[image_slider_no_space on_click=”prettyphoto” height=”600″ navigation_style=”light” images=”940,950,954,952,953,951″]